Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

38.52
-0.3800-0.98%
Volume:823.09K
Turnover:31.78M
Market Cap:4.03B
PE:-7.78
High:39.91
Open:38.00
Low:37.62
Close:38.90
52wk High:57.99
52wk Low:24.10
Shares:104.71M
Float Shares:96.32M
Volume Ratio:0.73
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.9500
EPS(LYR):-4.9500
ROE:-40.17%
ROA:-25.22%
PB:4.07
PE(LYR):-7.78

Loading ...

Crinetics Pharmaceuticals Director Stephanie Okey Disposes of Common Shares

Reuters
·
Mar 05

Crinetics Pharmaceuticals Drops BDO as Auditor and Hires PwC

Reuters
·
Mar 04

Why Crinetics Pharmaceuticals (CRNX) Is Down 7.1% After Deeper 2025 Loss And New US$207 Million Shelf Registration

Simply Wall St.
·
Mar 03

Crinetics Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Mar 02

Crinetics price target lowered to $96 from $105 at Citizens

TIPRANKS
·
Mar 02

Stock Track | Crinetics Pharmaceuticals Plummets 5.58% Intraday on Mixed Analyst Ratings

Stock Track
·
Feb 27

Piper Sandler Reaffirms Their Buy Rating on Crinetics Pharmaceuticals (CRNX)

TIPRANKS
·
Feb 27

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), QuidelOrtho (QDEL) and Akebia Therapeutics (AKBA)

TIPRANKS
·
Feb 27

Crinetics Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 27

Earnings Flash (CRNX) Crinetics Pharmaceuticals Posts Q4 Loss $1.29, vs. FactSet Est of $1.35 Loss

MT Newswires Live
·
Feb 27

Crinetics Pharma FY 2025 net loss hits USD 465.3 million, up 55.9%

Reuters
·
Feb 27

BRIEF-Crinetics Pharmaceuticals Q4 Net Income USD -122.815 Million

Reuters
·
Feb 27

Crinetics Pharmaceuticals Q4 Basic EPS USD -1.29

THOMSON REUTERS
·
Feb 27

Earning Preview: Crinetics Pharmaceuticals Inc. this quarter’s revenue is expected to increase by 555%, and institutional views are predominantly bullish

Earnings Agent
·
Feb 19

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Abbott Laboratories (ABT)

TIPRANKS
·
Feb 14

Crinetics Pharmaceuticals Participates in TD Cowen and Leerink Investor Conferences

Reuters
·
Feb 06

Crinetics Pharmaceuticals Inc : Stifel Raises Target Price to $84 From $75

THOMSON REUTERS
·
Jan 30

U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises

Reuters
·
Jan 30

Crinetics Pharmaceuticals Inc. to Report Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 27

Crinetics Pharmaceuticals Promotes Jeff Knight to Chief Development and Operating Officer

Reuters
·
Jan 26